methoctramine has been researched along with vecuronium bromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emala, CW; Hirshman, CA; Jooste, E; Klafter, F | 1 |
| Emala, CW; Jooste, E; Zhang, Y | 1 |
2 other study(ies) available for methoctramine and vecuronium bromide
| Article | Year |
|---|---|
A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
Topics: Animals; Atracurium; Binding, Competitive; Bronchial Spasm; Cell Membrane; CHO Cells; Cricetinae; Diamines; Indicators and Reagents; Muscarinic Antagonists; Neuromuscular Nondepolarizing Agents; Piperidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Vecuronium Bromide | 2003 |
Rapacuronium preferentially antagonizes the function of M2 versus M3 muscarinic receptors in guinea pig airway smooth muscle.
Topics: Animals; Diamines; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Indicators and Reagents; Muscarinic Antagonists; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Neuromuscular Nondepolarizing Agents; Nonlinear Dynamics; Parasympatholytics; Radioligand Assay; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Respiratory Muscles; Vecuronium Bromide | 2005 |